about
Platinum nanoparticles induce damage to DNA and inhibit DNA replicationInteractions between CdTe quantum dots and DNA revealed by capillary electrophoresis with laser-induced fluorescence detection.The effect of metal ions on Staphylococcus aureus revealed by biochemical and mass spectrometric analyses.Study of linkage between glutathione pathway and the antibiotic resistance of Escherichia coli from patients' swabs.Influence of microbiome species in hard-to-heal wounds on disease severity and treatment duration.Co-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted oMWCNTs for synergistic in vitro anti-cancer effects in non-small and small cell lung cancer.Apoferritin as an ubiquitous nanocarrier with excellent shelf life.Comparative study on toxicity of extracellularly biosynthesized and laboratory synthesized CdTe quantum dots.Effect of ampicillin, streptomycin, penicillin and tetracycline on metal resistant and non-resistant Staphylococcus aureus.Specific Magnetic Isolation of E6 HPV16 Modified Magnetizable Particles Coupled with PCR and Electrochemical DetectionA two-step protocol for isolation of influenza A (H7N7) virions and their RNA for PCR diagnostics based on modified paramagnetic particles.Interaction study of arsenic (III and V) ions with metallothionein gene (MT2A) fragment.Investigation of interaction between magnetic silica particles and lambda phage DNA fragment.Size-related cytotoxicological aspects of polyvinylpyrrolidone-capped platinum nanoparticles.DNA-magnetic Particle Binding Analysis by Dynamic and Electrophoretic Light Scattering.Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin.DNA interaction with zinc(II) ions.Site-Directed Conjugation of Antibodies to Apoferritin Nanocarrier for Targeted Drug Delivery to Prostate Cancer Cells
P50
Q33898518-129A311F-60E9-4907-9DED-ED15717DC400Q35198702-2728E6F2-30B8-4DEF-ABBF-054B86EFC5A4Q35238681-00FC561F-DD2C-4ADB-96F7-9B200A5D58EFQ35585474-07EDB2BB-5441-430D-B385-B4DB2908EE59Q35827717-F3880E82-0E44-490A-AD55-365AE92DC356Q38289946-3C021D54-3060-444C-9DDA-2281CB508588Q38708389-4B3DA9A8-0F98-4036-A5F9-6DF6E297A1B8Q38725850-DA63532C-389E-45B5-807C-4F88A2C868FBQ38758213-DDA56617-4BF6-4D1B-AA88-6F6EA42511B0Q40680529-1C544563-FF7C-40DB-BBA7-8000A65EF34BQ40775441-9E5D78AE-7D4B-4EDB-A42D-EB50F60C051EQ41740310-4C68FA65-F85D-462C-8451-631A0B86F3B5Q42272919-B18274CE-1148-485E-9DA3-95F63F0B83C3Q46372941-EE5B7EB3-3DF0-4D64-BD3B-DC52FCEDC8B7Q47443787-2DDF867C-A2A0-421B-AF51-E97AA8D35E81Q49772000-36AF9AF1-1EEF-4B08-A213-8D574C87AA1FQ54408865-C2A085BE-6E54-409E-91BD-AB3197A353B0Q61767313-07FBD2F0-A378-4A7E-84F4-A94AFB7EE03B
P50
description
biochemička
@cs
researcher ORCID ID = 0000-0003-0737-3144
@en
name
Simona Dostalova
@ast
Simona Dostalova
@en
Simona Dostalova
@es
Simona Dostalova
@nl
Simona Dostálová
@cs
type
label
Simona Dostalova
@ast
Simona Dostalova
@en
Simona Dostalova
@es
Simona Dostalova
@nl
Simona Dostálová
@cs
prefLabel
Simona Dostalova
@ast
Simona Dostalova
@en
Simona Dostalova
@es
Simona Dostalova
@nl
Simona Dostálová
@cs
P106
P21
P31
P496
0000-0003-0737-3144